PerkinElmer Set to Close Acquisition of Packard BioScience on Nov. 13 | GenomeWeb

NEW YORK, Nov. 12 – The Federal Trade Commission has approved PerkinElmer's proposed acquisition of Packard BioScience and the deal is now set to close on November 13, PerkinElmer said Monday.

"We will now move quickly to integrate these highly complementary businesses into the world's premier provider of drug discovery solutions," Grergory Summe, CEO of PerkinElmer, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.